CD133 and target therapy of tumor stem cells
10.3760/cma.j.issn.1673-422X.2010.09.007
- VernacularTitle:CD133与肿瘤干细胞靶向治疗
- Author:
Yu HAN
- Publication Type:Journal Article
- Keywords:
Neoplastic stem cells;
Target therapy
- From:
Journal of International Oncology
2010;37(9):661-664
- CountryChina
- Language:Chinese
-
Abstract:
CD133 is a stem cell surface antigen that has been recently identified as a potential cancer stem cell marker. CD133 is expressed in many solid tumors and has been associated with tumor resistance to chemotherapy and radiotherapy. As a transmembrane glycoprotein, CD133 received much attention as a molecular marker in targeted therapy of tumor stem cells and will bring new hope to cancer therapy.
